Please contact us for more information or to learn if you are eligible to participate.
The primary objective of this study is to assess the clinical performance of LIVERFAStTM In Vitro Diagnostic (IVD) Tests (Fibrosis score, Activity score and Steatosis score) in NAFLD suspected patients for staging of fibrosis and for grading of inflammatory activity and steatosis, taking as reference the liver biopsy with histological classification of the elementary lesions determined according to SAF scores
Principal Investigator | Fernando Membreno, MD |
Co-PI | Frank Cimino |
Sponsor | Fibronostics |
Type of Trial | Interventional |